Analysis On Investment Value Of Lised Company In Blood Product Industry

The last few years, the stock market in china is developed with unprecedented speed, but the stock market in china is still in its infancy.Price fluctuations and irrational components is still relatively large, so investors should abandon speculation mentality, establish a rational investment philosophy, then adopt the value investment strategy. A reasearch of corporate value contains three aspects:First, analyze the investment value of the industry which company place in, choose the company in the worthy industry. Second, use the legitimate public information (mainly the company's financial reports) to assess their prospects, and the company's management capabilities through the company's annual report. Third, assess the cost of capital securities, and use it to measure the possibly prospects for the company's share price area. Though the analysis of the industry,we can know how to invest, and through the company's financial report and the company's the disclosure information of management, we can use a company's valuation model to obtain a relatively effective value range of the company, and combine with the capital stock value and price to find the company and the stock market pricing differences to judge the company's current ability to create value. In this paper, taking the listed companies of the blood products industry, we explore the intrinsic investment value.The paper firstly introduce the blood products industry's macro-economic background, and is detailed to analyze the overall industry growth, periodicity and competitive market conditions, then analyzes the three typical companies on the basis of the financial statements(Hualan Biological Engineering.INC, Beijing Tiantan Biological Products Co.,LTD and Shanghai RAAS Blood Products Co.,Ltd) including their profitability, solvency, management ability, development ability, and the company investment value. Finally, the paper calculates the value of the three companies through valuation methods as PEG method,PEmethod and DCF method, to conclude that the blood products industry is a worthwhile investment industry. In this industry, Hualan Biological Engineering.INC and Shanghai RAAS Blood Products Co.,Ltd is the worthest to pay attention to.